PredxBio is a techbio company harnessing the power of spatial biology to unravel the hidden circuitries of the tumor micro-environment and leveraging the most advanced form of AI to get to the “Why?” of cancer with over 90% accuracy. They have successfully established a strong pipeline of customers, including pharmaceutical partners who investigate therapy response variations in their clinical trials.
